Vall d'Hebron Institut d'Oncologia - VHIO: Recent submissions
Now showing items 36-40 of 1251
-
Camizestrant in Combination with Three Globally Approved CDK4/6 Inhibitors in Women with ER+, HER2- Advanced Breast Cancer: Results from SERENA-1
(American Association for Cancer Research, 2025-10-15) -
PKA-driven SPP1 activation as a novel mechanism connecting the bone microenvironment to prostate cancer progression
(Springer Nature, 2025-10-07)



